doi: https://doi.org/10.1038/d41586-026-03166-0 This article is part of Nature Outlook: Parkinson’s disease, a supplement produced with financial support from Aspen Neuroscience, Inc. Nature maintains full independence in all editorial decisions related to the content. Med. 382, 1926–1932 (2020).
Nature 641, 971–977 (2025). Nature Biotechnol. 44, 70–78 (2026). Takahashi, K. & Yamanaka, S.
Cell 126, 663–676 (2006). Nature 641, 978–983 (2025). Nature Med. 32, 3449–3457 (2026).
Li, Y.-R., Chen, Y. & Yang, L. Trends Immunol. 47, 716–731 (2026). Cell Stem Cell 32, 710–726 (2025).
Parkinsons Dis. 11, 515–528 (2021). Nature 619, 606–615 (2023). Clearing the way for a transformative stem-cell treatment for Parkinson’s disease Tumour assembloids recapitulate tumour–CAF–T cell crosstalk in renal cancer Modelling mouse embryogenesis from chemically induced totipotent stem cells How the brain protects itself from Parkinson’s disease Progress accelerates in Parkinson’s treatments Senior Faculty Position in Cancer Research #537724 Virginia Tech Roanoke, VA Virginia Tech’s (VT) Fralin Biomedical Research Institute (FBRI) is re...
We are looking for highly motivated, energetic individuals to join our collaborative team at Mount Sinai and help push transplant medicine forward.... Levy Place, Annenberg 23, New York, NY 10029 We find Distinguished PIs, Senior PIs, Junior PIs, Senior Engineer, Junior Engineer, Post-doctoral fellow, Assistant research fellow. 1068 Xueyuan Avenue, Shenzhen 518055 P. China Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences（CAS)
Extract — continue reading at the source.
